inVentiv Health, Inc. has signed a definitive agreement to acquire Kforce Clinical Research, Inc. (KCR) for $50 million in cash. KCR will be combined with inVentiv’s existing functional service provider (FSP) and staffing businesses within the clinical segment. The transaction is expected to close at the end of March 2012.

KCR’s clinical services include: site management and monitoring, clinical project and program management, clinical programming and data management, biostatistical analysis and reporting, pharmacovigilance, medical writing, regulatory affairs, and quality assurance and training.

“With its strong clinical monitoring expertise, a customer-focused approach and an impressive portfolio of clients, Kforce Clinical Research is an attractive complement to inVentiv’s existing services. This acquisition expands our capability across the continuum of FSP, staffing and CRO services, further enhancing our ability to deliver flexible, cost-effective solutions for our clients,” said Paul Meister, chief executive officer of inVentiv Health.